MedPath

Retrospective study of the prognosis of Japanese patients with pulmonary hypertensio

Not Applicable
Recruiting
Conditions
pulmonary hypertension
Registration Number
JPRN-UMIN000026985
Lead Sponsor
agoya University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

Since this study is a retrospective study, we investigate all the cases which satisfy the inclusion criteria.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
In this study, primary end point is composite endpoint which meets the either criteria of the followings. 1) all cause death (cardiovascular death/ non-cardiovascular death) 2) worsening of pulmonary hypertension worsening of pulmonary hypertension is defined as a condition which meets both of the criteria as follows: a) worsening of the symptom due to pulmonary hypertension, b) necessity of adding oral pulmonary vasodilators, intravenous inotropes or intravenous vasopressors. worsening of the symptom due to pulmonary hypertension is defined as a condition which meets either criteria as follows: a) worsening of WHO functional class, b) worsening of the symptom due to rright heart failure and diuretics dose needs to be increased. 3) Necessity of any treatment as follows: atrial septostomy, lung transplantation, initiation of treatment with IV or SC prostanoids.
Secondary Outcome Measures
NameTimeMethod
1) death due to PH or hospitalization due to worsening of PH 2) worsening of the symptom due to pulmonary hypertension 3) change of hemodynamic parameters 4) change of the symptom using questionare. (PM-ADL8/SF-8/HADS) 5) change of laboratory examination 6) change of echocardiographic parameters 7) change of pulmonary function test 8) tapering or withdrawal of home oxygen therapy
© Copyright 2025. All Rights Reserved by MedPath